← Back to Clinical Trials
Recruiting Phase 4 NCT05839652

Treatment of Orthostatic Hypotension in SCI

Trial Parameters

Condition Hypotension
Sponsor James J. Peters Veterans Affairs Medical Center
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 25
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2023-07-01
Completion 2026-06-30
Interventions
Midodrine Hydrochloride

Brief Summary

The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.

Eligibility Criteria

Inclusion Criteria: * traumatic spinal cord injury * at least 12 months post injury * injury level of C1-T6 * AIS A, B or C * non-ambulatory * non-ventilator Exclusion Criteria: * Active psychiatric disorder * Stroke or cerebrovascular disease * Alzheimer's Disease or dementia * Unmanaged cardiac arrhythmias * Concurrent systemic, hepatic, or renal disease * Suspected or diagnosed malignancy * Neurological disease other than SCI * Self-reported history of three or more symptomatic episodes of AD per day

Related Trials